A novel pharmacodynamic approach to assess and predict tumor response to the epidermal growth factor receptor inhibitor gefitinib in patients with esophageal cancer
Soner Altiok, Heather Mezzadra, Sanjay Jagannath, Nancy Tsottles, Michelle A. Rudek, Nadia Abdallah, David Berman, Arlene Forastiere, Michael K. Gibson
Dive into the research topics of 'A novel pharmacodynamic approach to assess and predict tumor response to the epidermal growth factor receptor inhibitor gefitinib in patients with esophageal cancer'. Together they form a unique fingerprint.